|Bid||46.50 x 0|
|Ask||48.00 x 0|
|Day's Range||45.00 - 48.50|
|52 Week Range||31.00 - 153.00|
|Beta (5Y Monthly)||1.01|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
We feel now is a pretty good time to analyse Shield Therapeutics plc's ( LON:STX ) business as it appears the company...
Even if it's not a huge purchase, we think it was good to see that Timothy Watts, the CEO & Director of Shield...
Shield Therapeutics plc (LON:STX) shareholders will have a reason to smile today, with the analysts making substantial...